Advertisement
Artificial intelligence allows coronavirus disease 2019 to be detected and differentiated from community-acquired pneumonia on chest computed tomography

Artificial Intelligence Model Can Detect COVID-19 on Chest CT

0
Sensitivity and specificity for detecting COVID-19 90 and 96 percent, respectively, with AUC of 0.96
In a guideline issued by the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists

Guidance Issued for Perioperative Management of COVID-19 Patients

0
Dedicated OR equipped with negative pressure system, dedicated anesthesia machine required
National health expenditures are projected to increase at an average annual rate of 5.4 percent for 2019 to 2028

National Health Spending Expected to Increase Through 2028

0
National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
Leading up to the coronavirus disease 2019 outbreak

36 Percent of Available Hospital Beds Unoccupied on Typical Day

0
Leading up to COVID-19 outbreak, 2.2 hospital beds available per 1,000 persons, but most occupied
In a statement published online March 19 by the Infectious Diseases Society of America

IDSA Issues Recommendations for COVID-19 Testing

0
Four-tier approach prioritizes ICU patients, those with symptoms and contact with a patient or travel history
In a letter to the editor published online Feb. 25 in Surgical Infections

Anesthesia Procedure Outlined for Emergency Surgery in COVID-19 Patients

0
Fast induction of anesthesia with adequate muscle relaxation recommended to prevent cough
In a special article published online March 17 in Clinical Gastroenterology and Hepatology

Information on COVID-19 Provided for Gastroenterologists

0
COVID-19 can include GI symptoms such as diarrhea; gastrointestinal tract is potential route of infection
Sleep-disordered breathing is associated with changes in the brain

Sleep-Disordered Breathing Tied to Brain Changes

0
Greater amyloid burden seen in regions of the brain tied to Alzheimer disease
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.

Shortages Seen for Drugs That Show Promise Against COVID-19

0
Patients who currently rely on remdesivir or hydroxychloroquine now facing dangerous shortages
Insulin and other biologic drugs

FDA: Insulin Among Drugs Transitioned to Biological Products

0
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions